Brain Cancer

The OncLive Brain Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of brain cancer, including glioma, glioblastoma multiforme, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in brain cancer.


Latest News

FDA Issues Complete Response Letter for Omburtamab BLA for Pediatric Metastatic Neuroblastoma
FDA Issues Complete Response Letter for Omburtamab BLA for Pediatric Metastatic Neuroblastoma

December 2nd 2022

The FDA has issued a complete response letter to the biologics license application seeking the approval of 131I-omburtamab for the treatment of pediatric patients with central nervous system/leptomeningeal metastases from neuroblastoma.

FDA Grants Orphan Drug Designation to AUM302 for Neuroblastoma
FDA Grants Orphan Drug Designation to AUM302 for Neuroblastoma

December 2nd 2022

DCVax-L Improves Survival in Glioblastoma
DCVax-L Improves Survival in Glioblastoma

November 18th 2022

ODAC Votes Against Omburtamab for Pediatric Metastatic Neuroblastoma
ODAC Votes Against Omburtamab for Pediatric Metastatic Neuroblastoma

October 31st 2022

FDA Raises Questions About BLA for Omburtamab in Pediatric Metastatic Neuroblastoma
FDA Raises Questions About BLA for Omburtamab in Pediatric Metastatic Neuroblastoma

October 27th 2022

Video Series
Video Interviews
Podcasts

More News